Chemoradiation is considered a reasonable treatment option for patients with locally advanced, unresectable pancreatic cancer. The chemotherapy agents 5-fluorouracil, gemcitabine, capecitabine and ...

Historically, high-dose radiation has been considered beneficial for improving survival rates in patients with unresectable pancreatic cancer. Yet, the application has often been limited due to ...

Approximately 30% of pancreatic cancer patients present with locally unresectable disease with no evidence of distant metastases. Local control in this patient population can provide effective ...

The San Francisco biotech confirmed that neither the PanCAN Precision Promise study in metastatic pancreatic cancer nor the LAPIS trial in patients with locally advanced, unresectable pancreatic ...

which is designed for treating locally advanced unresectable pancreatic cancer. The device offers a targeted treatment approach by delivering Phosphorous-32 directly into pancreatic tumors ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a ...